Biocryst Pharmaceuticals Inc (BCRX)
R&D Expenses
$51.97M
Quarterly · Period ending: · USD
BCRX R&D Expenses
Latest reported$51.97Mperiod ending
Latest reported$51.97Mperiod ending
BCRX Quarterly R&D Expenses ($0.00 → $51.97M)
Quarterly R&D Expenses
High-resolution chart · PNG
BCRX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,714,000 | |
| 2,530,000 | |
| 2,914,352 | |
| 2,038,000 | |
| 2,702,000 | |
| 1,936,380 | |
| 1,800,000 | |
| 1,900,000 | |
| 1,800,000 | |
| 2,200,000 | |
| 1,600,000 | |
| 2,400,000 | |
| 2,600,000 | |
| 2,700,000 | |
| 2,800,000 | |
| 2,400,000 | |
| 2,500,000 | |
| 2,900,000 | |
| 0 | |
| 2,200,000 | |
| 1,900,000 | |
| 1,500,000 | |
| 0 | |
| 1,700,000 | |
| 1,300,000 | |
| 2,500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |